Extended Treatment in Metastatic Breast Cancer With Eribulin
Clinical trial NCT02769364 · COMPLETED
Trial details
- NCT number
- NCT02769364
- Sponsor
- Eisai Limited
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-06-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.